Top Markets
Coin of the day
Curanex Pharmaceuticals Inc Common Stock Curanex Pharmaceuticals Inc Common Stock

Curanex Pharmaceuticals Inc Common Stock

CURX
Classifica tra le azioni #34063
Curanex Pharmaceuticals Inc. is an emerging biopharmaceutical company focused... Curanex Pharmaceuticals Inc. is an emerging biopharmaceutical company focused on identifying, advancing, and bringing to market plant-based medicines to address various inflammatory conditions. Their primary drug candidate, Phyto-N, is currently in development for a broad spectrum of health issues, including but not limited to ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, gout, and acne. Established in 1996 and based in Jericho, New York, the company was formerly known as Fordman Pharma Inc. before adopting its current name in November 2023.
Prezzo delle azioni
$0.223
Ultima sincronizzazione: 2026-08-14
Capitalizzazione di mercato
$6.32M
Variazione (1 giorno)
1.64%
Variazione (1 anno)
-
Paese
US
Scambia Curanex Pharmaceuticals Inc Common Stock (CURX)

Categoria

EPS per Curanex Pharmaceuticals Inc Common Stock (CURX)
EPS al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Curanex Pharmaceuticals Inc Common Stock, l’EPS attuale della società (TTM) è 0. Alla fine del 2026, la società aveva un EPS di 0 uguale a rispetto a quello del 2026, che era di 0.
Storico EPS per Curanex Pharmaceuticals Inc Common Stock da 2026 a 2026
EPS alla fine di ogni anno
Anno EPS Cambia
Non abbastanza dati per le date fornite.
EPS per aziende simili o concorrenti
Azienda EPS Differenza di EPS Il paese
$17.32 -
US
$27.74 -
NL
- -
CH
- -
KR
$13.70 -
BE